BioLife Solutions, Inc.BLFSNASDAQ
LOADING
|||
Net Income Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year net income growth rate
Latest
103.92%
↓ 73% below average
Average (39q)
385.98%
Historical baseline
Range
High:32616.20%
Low:-19365.82%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 103.92% |
| Q2 2025 | -3435.27% |
| Q1 2025 | -103.60% |
| Q4 2024 | 831.59% |
| Q3 2024 | 91.78% |
| Q2 2024 | -102.71% |
| Q1 2024 | 23.63% |
| Q4 2023 | 54.06% |
| Q3 2023 | -185.64% |
| Q2 2023 | 25.63% |
| Q1 2023 | 72.12% |
| Q4 2022 | -394.02% |
| Q3 2022 | 86.28% |
| Q2 2022 | -926.80% |
| Q1 2022 | 53.57% |
| Q4 2021 | -19365.82% |
| Q3 2021 | -99.00% |
| Q2 2021 | 804.47% |
| Q1 2021 | 47.49% |
| Q4 2020 | -87.91% |
| Q3 2020 | 93.08% |
| Q2 2020 | -173.43% |
| Q1 2020 | 4537.84% |
| Q4 2019 | -94.84% |
| Q3 2019 | 1011.69% |
| Q2 2019 | 96.25% |
| Q1 2019 | -52.18% |
| Q4 2018 | -27.44% |
| Q3 2018 | 8.04% |
| Q2 2018 | 32616.20% |
| Q1 2018 | 100.62% |
| Q4 2017 | -75.08% |
| Q3 2017 | 58.51% |
| Q2 2017 | 11.73% |
| Q1 2017 | 73.82% |
| Q4 2016 | -243.03% |
| Q3 2016 | 28.54% |
| Q2 2016 | -10.54% |
| Q1 2016 | -9.60% |
| Q4 2015 | -4.74% |